SIG Brokerage’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Buy
+1,476
New +$221K ﹤0.01% 822
2025
Q2
Sell
-3,239
Closed -$361K 822
2025
Q1
$361K Buy
+3,239
New +$345K 0.02% 407

Other funds holding NVS

SIG Brokerage's NVS Position: Q2 2026 in Review

SIG Brokerage opened a new position in Novartis (NVS) in Q2 2026: 1,476 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #822 among its holdings. This is a return to the name: SIG Brokerage previously reported a position in NVS as recently as Q1 2025.

SIG Brokerage first reported a position in NVS in Q1 2025 and has held it in 2 quarters since. The position peaked at $361K in Q1 2025. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • SIG Brokerage held 1,476 shares of Novartis worth $231K as of Q2 2026.
  • Novartis was a new SIG Brokerage position in Q2 2026.
  • Novartis made up ﹤0.01% of SIG Brokerage's portfolio in Q2 2026, its #822 holding.
  • SIG Brokerage first reported a position in Novartis in Q1 2025 and has held it in 2 quarters since.
  • SIG Brokerage's Novartis position peaked at $361K in Q1 2025.
  • 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.